REGULATORY AFFAIRS OUTSOURCING WHY

Similar documents
REGULATORY AFFAIRS OUTSOURCING

CAN QUALITY BE OUTSOURCED? dictated by good business practices. that quality is a product or service: that consistently has zero defects

SUPPLIERS SELECTION AND ASSESSMENT

EXPERT ISE YOU CAN TRUST

Emerging Trends in Regulatory Outsourcing WHITE PAPER.

Who We Are / Services

Your Complete Quality Solution Provider for the Life Science Industry

REGULATORY RESOURCES GROUP. a different approach. a range of services to suit your needs

RENEWABLE ENERGY & CARBON ABATEMENT

Maintenance of Mature and Generic Products

WHITE PAPER. Overview

DIFFERING CMC REQUIREMENTS: US AND EU

GMP.. A Journey of 1000 miles starts with 1st Step.Induction.

Strategic Outsourcing for Success

EUROPEAN COMMISSION ENTERPRISE DIRECTORATE-GENERAL QUESTIONS. and ANSWERS

Revision of the Variations Regulation. Key Principles and Guidelines Development CONTENT

Outsource or in-house? The evolving role of analytical services in pharmaceutical manufacturing

PPTA Regulatory Workshop June 13, 2016

GxP Auditing, Remediation, and Staff Augmentation

GxP Auditing, Remediation, and Staff Augmentation

Innovative Solutions for the Life Sciences

Which Regulation Fits Where?

Convert Advisor Subscriptions to CSP The Easy Way

Connecting the parts Developing an integrated IDMP strategy

Overview of global registration of vaccines

GxP Auditing, Remediation, and Quality System Resourcing

Impact factor: 3.958/ICV: 4.10 ISSN:

MANAGING MATURE PRODUCT PORTFOLIOS - KEY CHALLENGES AND BENEFITS

Regulatory Affairs, Compliance Assurance, Quality Systems, Remediation Strategy and Support, and Strategic Consulting Services

SOFTWARE VALIDATION CASE STUDY

Managed IT Services. Eliminating technology pains in small businesses

PATH s Guiding Principles for Managing Conflict of Interest

Drug Registration in BRICS countries: Opportunities and Challenges. Judith ter Horst 1 November 2018

Brochure. Asset integrity solutions Improve integrity and reduce costs through more effective asset management

Public release of clinical information in drug submissions and medical device applications

Oliver Wyman "Value Pricing" study The unfounded fear of price rises

Challenges and Opportunities in the Global Regulatory Environment

Conditional marketing authorisation

Corporate Overview. Intelligent compliance. Sustainable progress. A safer world. 1

The ISO Solved solution was build to accomplish the following in most optimised and automated way possible.

DISCOVER OUR SEGMENT GLP AND REGULATORY/ SCIENTIFIC ARCHIVING

13 October Structured Product Labeling: Four Strategies to Comply with FDA s SPL Mandate

Need a Security Workforce Management Platform?

The Science Behind Smart Outsourcing: Four Steps to Success

FIVE SECRETS OF GREAT PUBLISHERS

PhlexEview: Transforming Costly Paper Processes into Value Driven Compliance

IDMP update: A practical approach to IDMP implementation and the impact of the possible new phasing

Managed IT Services. Eliminating technology pains for small businesses

Post approval change of Japanese registration dossiers and impact on market supply

Epic Integrated Consulting Services Seamless integration for system implementation, transition, optimization, legacy support and training

MEDICINES CONTROL COUNCIL

Coraggio s Strategic Clarity Framework. clarity focus action. vision mission values reputation position imperatives objectives initiatives

Unlocking hidden value within regulatory affairs

QUICK FACTS. Delivering a Managed Services Solution to Satisfy Exponential Business Growth TEKSYSTEMS GLOBAL SERVICES CUSTOMER SUCCESS STORIES

Strategic Corporate Goals: Vision & Mission 2020

3M Drug Delivery Systems. April 26, 2011

THE COMMON TECHNICAL DOCUMENT: TAKING INDIAN NDA PROCESS TOWARDS GLOBALIZATION

Life Sciences Courseware. Knowledge. Performance. Impact.

innovation..collaboration..supply chain..stakeholder engagement.. interoperability..international standards

I D C T E C H N O L O G Y S P O T L I G H T

Customer back on top of the supply chain agenda in 2010

Moving from ISO 9001:2008 to ISO 9001:2015 Transition Guide

T H E P R O P O S A L F O R T H E Y E A R

PMO In A Box. Prepared for UBS

Best practice of worldwide product variations regarding planning, conduct and implementation

Power your Order to Cash Cycle Get the cash impact you need

Liverpool City Council case study. How we implemented a seamless DBS system

Table of Contents. Presented by

Health Care Viewpoint

WE CARE MEDTECH.

MANAGING AND INTEGRATING CLINICAL TRIAL DATA: A Challenge for Pharma and their CRO Partners

Managed IT Services. Eliminating technology pains for small businesses

OASIS DITA Pharma. Initial Meeting 30 July 2009

POD & CDLP China 2016 Digital Production Printing, Print On Demand, and Color Digital Label & Package Printing Market Opportunities in China

Prospectus. In-House Production Printing Critical Trends for Corporations, Government, Education, and Non-Profits

Ensuring Quality & Regulatory Compliance when Collaborating with a Service Provider

2005 Survey Results for f E-Myth Worldwide s Mastery Program Coaching Clients

Moving to the AS9100:2016 series. Transition Guide

A practical guide to achieving and maintaining global oversight and ensuring end-to-end pharmacovigilance

Job Openings at SoliPharma

Asset integrity solutions. Improve integrity and reduce costs through more effective asset management. prime. Risk. Assessment.

Putting the right people and procedures in place to help keep employees safe. internationalsos.com

MAXIMIZER: Maximize the use of your operation footprint and assets to reduce costs

Managed IT Services. Eliminating technology pains in small businesses

BC Timber Sales Strategic Plan Ministry of Forests, Lands and Natural Resource Operations

The 23 rd Autumn Introductory Course:

Making the right choice: Evaluating outsourced revenue cycle services vendors

Ecolomondo Corporate Overview

GordanJacobsTM. EVV Management Service Solution Overview E V V S E R V I C E B U R E A U. v1.0

ROAD MAP. Road Map Avoiding 11 Pitfalls of System Conversions

Maintenance Management.

IMARC Research, Inc. Executive Summary. Independent. Monitoring. Auditing. Research. Consulting WE LL EARN YOUR APPROVAL.

Managed IT Services. Eliminating technology pains in small businesses

Moving to the AS/EN 9100:2016 series. Transition Guide

Indirect Tax Conference Developing your Customs Function

Managed IT Services. Eliminating technology pains for small businesses

A Successful Model for Outsourcing Core Labeling Activities

Di Renzo Regulatory Affairs ROME - MILAN - LONDON

Managed IT Services. Eliminating technology pains in small businesses

Transcription:

REGULATORY AFFAIRS OUTSOURCING WHY Y SHOULD YOU OUTSOURCE? Regulatory Affairs Unit in a pharmaceutical company is a vital and dynamic unit that drives the R & D efforts of the company to the market successfully. It works with a focus to get products onto the market with a commercially viable label in the least possible time and expenses. Today the world has become a global village and many companies are in a race to place new products onto the world markets and to gain market share and increase earnings. In such a scenario a small delay in gaining market access means huge loss in terms of market share and revenue generated. The key to success for pharmaceutical companies lies in obtaining timely marketing approval from regulators. So to obtain timely marketing approval companies can either strengthen they regulatory department or outsource the tasks to regulatory affairs consulting firm. With changing global regulatory environment and requirements, outsourcing regulatory affairs work seems a more beneficial option both in terms of time and money. Maintaining a large regulatory affairs department can be very expensive and scope of knowledge can be limited to certain aspects. On the other hand, a regulatory affairs consultant keeps on updating himself with the current regulations and has vital experience in the field to expedite the approval process. Pag. 1 / 6

SHORT-TERM VS. LONG-TERM OUTSOURCING Regulatory affairs services can range from simple tasks to very complex projects involving detailed consultation with the relevant guidelines and/or concerned Health Agencies. Outsourcing basically breaks down into two categories: 1) SHORT-TERM 2) LONG-TERM The first step in the decision to outsource is determining into which category your needs fall. The need for short-term outsourcing can result from a special situation within a company providing temporary relief of bottleneck situations when a regulatory affairs department is overwhelmed by large volume of projects, suffering from shortage of personnel or of slow output. LONG-TERM OUTSOURCING, on the other hand, involves a long-term partnership. By utilizing this type of outsourcing, a regulatory affairs department can gain many long-term benefits, including decreased fix costs of human resources and the ability to with projects of lower priority. Identifying what services will best suit your needs is a critical step in the decision to outsource and in the selection of right partner. Pag. 2 / 6

SOME KEY FACTORS FOR SELECTING A REGULATORY AFFAIRS PARTNER EXPERIENCE: Experience in pharmaceutical industry is an essential factor for pharmaceutical regulatory consultants. Consultants should have experience in strategic planning and implementation of regulatory plans as well as in preparation and submission of regulatory documents. CONFIDENTIALITY: A Confidentiality agreement has to be in place to protect your company s proprietary knowledge. A consultant s confidentiality can be evaluated by requesting previous studies, and information shared can be used to judge the same. RESOURCES: A company must have adequate staff and/or collaboration with other service providers to serve ongoing projects without delay. The involved staff must be highly skilled and trained to carry out regulatory work. FLEXIBILITY: The regulatory affairs services should be tailormade meeting the specific needs of the clients. The services should be available an a modular basis. INFRA-STRUCTURE: The service company should have in place standard system/technology and infrastructure to carry out the work effectively.. Pag. 3 / 6

OUR REGULATORY AFFAIRS SKILLS EFFICIENT REGULATORY STRATEGY MAKES THE DIFFERENCE Our team works proactively and proposes the regulatory strategy which will bring the product to market on the desired day. Taking into account all relevant parameters, including the client s timelines, marketing plans, budget and other special arrangements, we complete and implement the regulatory plan in order to ensure timely product launch in each concerned country. E-CTD PREPARATION ectd submissions are increasingly preferred by the European regulatory authorities. We offer dossier preparation in both CTD or ectd as well as converting paper CTD to fully compliant ectd. Pag. 4 / 6

CTP SYSTEM IS THE RIGHT CHOICE SITE COMPLIANCE & REGULATORY GAP Analysis DMF, CTD, TF compilation and review (all modules) Post marketing applications (Variations and renewals) Regulatory support from development to MA granting and beyond SUBMISSION SUPPORT Marketing authorisation applications National, DCPs and MRPs Regulatory support in FDA procedure ectd Training Software Validation Pag. 5 / 6

A global system, a perfect mechanism, an organic approach. CTP SYSTEM: the solution. PLANNING FOR THE FUTURE Regulatory Affairs outsourcing is on a growth worldwide: many large and small companies have adopted this strategy to get a timely approval. Even multinational firms are outsourcing their regulatory work to lessen the pressure on their in-house team or to support the same. Outsourcing is "one of the greatest organizational and industry structure shifts of the century." w w w. c t p s y s t e m. c o m i n f o @ c t p s y s t e m. c o m Località Salceto, 91/93 53036 Poggibonsi (Siena) Tel. +39 0577 98481 Via G. Stephenson, 94 20157 Milano Tel. +39 02 49681311 Via Campobello, 7 00040 Pomezia (Roma) Tel. +39 06 9122873 Fax +39 0577 980762 Fax +39 02 49681344 Fax +39 06 9120289 Pag. 6 / 6